You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

À propos des lignes directrices

Displaying Guidelines

141 articles

Fulvestrant for Systemic Therapy of Locally Advanced or Metastatic Breast Cancer in Postmenopausal Women: Guideline Recommendations

Document Status: Archived
ID: 1-13

Sep 2008

Guidance on the Substitution of Systemic Therapy Agents

Document Status: Current
ID: GL-C50-33
Version: 1

Aug 2017

Hepatitis B Virus Screening and Management for Patients Receiving Systemic Treatment

Document Status: Current

Sep 2022

Ifosfamide-based Combination Chemotherapy in Advanced Soft Tissue Sarcoma

Document Status: Archived
ID: 11-4

Sep 2011

Indications for Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery

Document Status: Current
ID: GL 17-12
Version: N/A

Sep 2019

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Document Status: In-Review
ID: 7-13

Oct 2017

Kadcyla® Trastuzumab Emtansine Safety Reminder

Document Status: Current
ID: GL-C50-15

Jun 2014

Liposomal Anthracyclines in the Management of HIV-positive Kaposi's Sarcoma

Document Status: Archived
ID: 12-8
Version: 2

Jun 2013

Locoregional Management of In-Transit Metastasis in Melanoma

Document Status: Current
ID: GL 8-10
Version: N/A

Feb 2020

Management of Cancer Medication-Related Infusion Reactions

Document Status: Current
Version: 1

Aug 2019

Management of Early-Stage Hodgkin Lymphoma

Document Status: Current
ID: GL 6-20
Version: 2

May 2023

Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Document Status: Current
ID: GL SCT-8

Oct 2017